{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T13:26:17Z","timestamp":1780579577752,"version":"3.54.1"},"reference-count":18,"publisher":"Japanese Society for Lymphoreticular Tissue Research","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCEH","J Clin Exp Hematopathol"],"published-print":{"date-parts":[[2022]]},"DOI":"10.3960\/jslrt.21028","type":"journal-article","created":{"date-parts":[[2022,4,26]],"date-time":"2022-04-26T22:09:16Z","timestamp":1651010956000},"page":"106-113","source":"Crossref","is-referenced-by-count":5,"title":["PD-L1-expressing extranodal diffuse large B-cell lymphoma, NOS with and without &lt;i&gt;PD-L1&lt;\/i&gt; 3\u2019-UTR structural variations"],"prefix":"10.3960","volume":"62","author":[{"given":"Taishi","family":"Takahara","sequence":"first","affiliation":[{"name":"Department of Surgical Pathology, Aichi Medical University Hospital, Nagakute, Japan,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eri","family":"Ishikawa","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Nagoya University Graduate School of Medicine, Nagoya, Japan,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuka","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Nagoya University Hospital, Nagoya, Japan,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasunori","family":"Kogure","sequence":"additional","affiliation":[{"name":"Division of Molecular Oncology, National Cancer Center Research Institute, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Sato","sequence":"additional","affiliation":[{"name":"Department of Surgical Pathology, Aichi Medical University Hospital, Nagakute, Japan,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keisuke","family":"Kataoka","sequence":"additional","affiliation":[{"name":"Division of Molecular Oncology, National Cancer Center Research Institute, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeo","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Nagoya University Hospital, Nagoya, Japan,"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2349","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Sakakibara A, Kohno K, Ishikawa E <i>et al.<\/i> Age-related EBV-associated B-cell lymphoproliferative disorders and other EBV + lymphoproliferative diseases: new insights into immune escape and immunodeficiency through staining with anti-PD-L1 antibody clone SP142. Pathol Int. 2020; 70: 481-492.","DOI":"10.1111\/pin.12946"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Suzuki Y, Sakakibara A, Shimada K <i>et al.<\/i> Immune evasion-related extranodal large B-cell lymphoma: A report of six patients with neoplastic PD-L1-positive extranodal diffuse large B-cell lymphoma. Pathol Int. 2019; 69: 13-20.","DOI":"10.1111\/pin.12742"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Ishikawa E, Nakamura M, Shimada K <i>et al.<\/i> Prognostic impact of PD-L1 expression in primary gastric and intestinal diffuse large B-cell lymphoma. J Gastroenterol. 2020; 55: 39-50.","DOI":"10.1007\/s00535-019-01616-3"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Chen J, Jiang CC, Jin L, Zhang XD. Regulation of PD-L1: a novel role of pro-survival signalling in cancer. Ann Oncol. 2016; 27: 409-416.","DOI":"10.1093\/annonc\/mdv615"},{"key":"5","unstructured":"5 Swerdlow SH, Campo E, Harris NL, et al. WHO Classification of Tumors of Haematopoietic and Lymphoid Tissues. 4th ed, Lyon, IARC, World Health Organization. 2017."},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Younes A, Santoro A, Shipp M <i>et al.<\/i> Nivolumab for classical Hodgkin\u2019s lymphoma after failure of both autologous stem-cell transplantation and brentuximab vedotin: a multicentre, multicohort, single-arm phase 2 trial. Lancet Oncol. 2016; 17: 1283-1294.","DOI":"10.1016\/S1470-2045(16)30167-X"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Kataoka K, Shiraishi Y, Takeda Y <i>et al.<\/i> Aberrant PD-L1 expression through 3\u2032-UTR disruption in multiple cancers. Nature. 2016; 534: 402-406.","DOI":"10.1038\/nature18294"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Ishikawa E, Kato S, Shimada K <i>et al.<\/i> Clinicopathological analysis of primary intestinal diffuse large B-cell lymphoma: prognostic evaluation of CD5, PD-L1, and Epstein-Barr virus on tumor cells. Cancer Med. 2018; 7: 6051-6063.","DOI":"10.1002\/cam4.1875"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Yamashita D, Shimada K, Kohno K <i>et al.<\/i> PD-L1 expression on tumor or stromal cells of nodal cytotoxic T-cell lymphoma: A clinicopathological study of 50 cases. Pathol Int. 2020; 70: 513-522.","DOI":"10.1111\/pin.12950"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Shimada K, Yoshida K, Suzuki Y <i>et al.<\/i> Frequent genetic alterations in immune checkpoint-related genes in intravascular large B-cell lymphoma. Blood. 2021; 137: 1491-1502.","DOI":"10.1182\/blood.2020007245"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Nguyen MC, Shah MH, Liebner DA <i>et al.<\/i> The adrenal gland as a sanctuary site of metastases after pembrolizumab treatment: A case series. J Natl Compr Canc Netw. 2018; 16: 1279-1283.","DOI":"10.6004\/jnccn.2018.7059"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Chapuy B, Roemer MGM, Stewart C <i>et al.<\/i> Targetable genetic features of primary testicular and primary central nervous system lymphomas. Blood. 2016; 127: 869-881.","DOI":"10.1182\/blood-2015-10-673236"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Casellas R, Basu U, Yewdell WT <i>et al.<\/i> Mutations, kataegis and translocations in B cells: understanding AID promiscuous activity. Nat Rev Immunol. 2016; 16: 164-176.","DOI":"10.1038\/nri.2016.2"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Good-Jacobson KL, Szumilas CG, Chen L <i>et al.<\/i> PD-1 regulates germinal center B cell survival and the formation and affinity of long-lived plasma cells. Nat Immunol. 2010; 11: 535-542.","DOI":"10.1038\/ni.1877"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Noguchi T, Ward JP, Gubin MM <i>et al.<\/i> Temporally distinct PD-L1 expression by tumor and host cells contributes to immune escape. Cancer Immunol Res. 2017; 5: 106-117.","DOI":"10.1158\/2326-6066.CIR-16-0391"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Takahashi T, Tateishi A, Bychkov A, Fukuoka J. Remarkable alteration of PD-L1 expression after immune checkpoint therapy in patients with non-small-cell lung cancer: two autopsy case reports. Int J Mol Sci. 2019; 20: 2578.","DOI":"10.3390\/ijms20102578"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17 Takahara T, Satou A, Ishikawa E <i>et al.<\/i> Clinicopathological analysis of neoplastic PD-L1-positive EBV+ diffuse large B cell lymphoma, not otherwise specified, in a Japanese cohort. Virchows Arch. 2021; 478: 541-552.","DOI":"10.1007\/s00428-020-02901-w"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18 Escors D, Gato-Ca\u00f1as M, Zuazo M <i>et al.<\/i> The intracellular signalosome of PD-L1 in cancer cells. Signal Transduct Target Ther. 2018; 3: 26.","DOI":"10.1038\/s41392-018-0022-9"}],"container-title":["Journal of Clinical and Experimental Hematopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jslrt\/62\/2\/62_21028\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,2]],"date-time":"2022-07-02T06:05:26Z","timestamp":1656741926000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jslrt\/62\/2\/62_21028\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"references-count":18,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.3960\/jslrt.21028","relation":{},"ISSN":["1346-4280","1880-9952"],"issn-type":[{"value":"1346-4280","type":"print"},{"value":"1880-9952","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022]]},"article-number":"21028"}}